These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21410609

  • 21. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P.
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D, From L, Ricciatti D, Shapero H.
    Can Med Assoc J; 1978 Jan 21; 118(2):154-6. PubMed ID: 757383
    [Abstract] [Full Text] [Related]

  • 25. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC.
    Arch Dermatol; 1993 Jan 21; 129(1):92-6. PubMed ID: 8420497
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R, Nelle M, Schaible T.
    Crit Care Med; 2011 Jun 21; 39(6):1521-32. PubMed ID: 21358399
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC.
    Rev Prat; 2007 Jun 15; 57(11):1165-70. PubMed ID: 17691257
    [Abstract] [Full Text] [Related]

  • 34. Erythema Multiforme Versus Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Subtle Difference in Presentation, Major Difference in Management.
    Newkirk RE, Fomin DA, Braden MM.
    Mil Med; 2020 Sep 18; 185(9-10):e1847-e1850. PubMed ID: 32373930
    [Abstract] [Full Text] [Related]

  • 35. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M, Wiesend CL, Vetter R, Weiss J, Blaschke S, Norgauer J, Mockenhaupt M.
    Arch Dermatol; 2007 Jun 18; 143(6):711-6. PubMed ID: 17576936
    [Abstract] [Full Text] [Related]

  • 36. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations.
    Hockett KC.
    Clin J Oncol Nurs; 2004 Feb 18; 8(1):27-30, 55. PubMed ID: 14983759
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ethambutol-induced toxic epidermal necrolysis.
    Pegram PS, Mountz JD, O'Bar PR.
    Arch Intern Med; 1981 Nov 18; 141(12):1677-8. PubMed ID: 7305578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.